Lipid nanoparticles

Lipid nanoparticles (LNPs) enable the delivery of a variety of molecules, including nucleic acids such as mRNA, to cells and are therefore an essential tool in gene therapy. To unleash the potential of vaccines, protein and gene therapies, drug developers need the support of a trusted and experienced provider of novel functional excipients who understands how to overcome biological barriers and optimize new and emerging drugs. Evonik Health Care has decades of experience working with all types of drug delivery technologies including lipids, lipid formulations and lipid production methods. With its laboratories near Vancouver, British Columbia, formerly known as Transferra Nanosciences Inc. or Northern Lipids, Evonik Health Care is a leading CDMO for lipid nanoparticles and liposome-based formulations.